Reuters logo
BRIEF-UCB to file for Brivaracetam approval in early 2015
July 23, 2014 / 5:16 AM / in 3 years

BRIEF-UCB to file for Brivaracetam approval in early 2015

July 23 (Reuters) - Ucb Sa

* Positive topline phase 3 results for Brivaracetam in epilepsy patients with partial-onset seizures

* Results showed that Brivaracetam reduced partial-onset seizure frequency and improved responder rates, both with statistical significance

* Plans to submit a new drug application to US FDA and a marketing authorization application to the European Medicines Agency (EMA) in early 2015 Source text for Eikon: bit.ly/1nT1X9C Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below